Acumen Pharmaceuticals (ABOS) Stock Chart & Stock Price History $1.18 -0.09 (-7.09%) Closing price 04:00 PM EasternExtended Trading$1.19 +0.01 (+1.19%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Acumen Pharmaceuticals Stock Price Performance The Acumen Pharmaceuticals (ABOS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 54.96%, with a year-to-date return of -31.40%. In the past month, the stock has increased 20.40%, reflecting recent market activity. As of the latest close, Acumen Pharmaceuticals traded at $1.27 with a market cap of $76.93 million and volume of 461,263 shares. Receive ABOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.28%1 Month Performance+20.40%3 Month Performance-1.67%Year-To-Date Performance-31.40%1 Year Performance-54.96% ABOS Stock Chart for Tuesday, June, 10, 2025 ABOS Chart by TradingView Acumen Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/10/2025$1.27$1.18-7.09%$1.28$1.17264,481 shs$71.48 million06/09/2025$1.20$1.27+5.83%$1.28$1.19461,263 shs$76.93 million06/06/2025$1.07$1.20+12.15%$1.21$1.06383,414 shs$72.69 million06/05/2025$1.07$1.07$1.09$1.03174,467 shs$64.81 million06/04/2025$1.04$1.07+2.88%$1.07$1.00246,646 shs$64.81 million06/03/2025$1.00$1.04+4.00%$1.06$1.00336,225 shs$63.00 million06/02/2025$1.02$1.00-1.96%$1.04$1.00109,357 shs$60.57 million05/30/2025$1.05$1.02-2.86%$1.05$1.01135,912 shs$61.78 million05/29/2025$1.02$1.05+2.94%$1.05$1.01248,161 shs$63.60 million05/28/2025$1.02$1.02$1.06$0.99337,602 shs$61.78 million Get the Latest News and Ratings for ABOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/27/2025$1.02$1.02$1.04$0.99348,458 shs$61.78 million05/26/2025$1.02$1.02$1.04$0.99329,394 shs$61.78 million05/23/2025$1.03$1.02-0.97%$1.04$0.99329,394 shs$61.78 million05/22/2025$1.04$1.03-0.96%$1.09$1.00450,599 shs$62.39 million05/21/2025$1.06$1.04-1.89%$1.09$1.03249,692 shs$63.00 million05/20/2025$1.07$1.06-0.93%$1.08$1.03112,379 shs$64.21 million05/19/2025$1.07$1.07$1.07$1.0197,456 shs$64.81 million05/16/2025$1.01$1.07+5.94%$1.09$1.00165,356 shs$64.81 million05/15/2025$0.98$1.01+3.06%$1.02$0.9792,182 shs$61.18 million05/14/2025$1.05$0.98-6.67%$1.07$0.97155,135 shs$59.36 million05/13/2025$1.05$1.05$1.06$0.98312,349 shs$63.60 million05/12/2025$0.98$1.05+7.13%$1.05$0.98168,860 shs$63.60 million05/09/2025$1.01$0.98-2.48%$1.02$0.98129,655 shs$59.37 million Related Companies AARD Stock Chart MDWD Stock Chart TVGN Stock Chart ANNX Stock Chart FHTX Stock Chart SLRN Stock Chart DSGN Stock Chart URGN Stock Chart CRDF Stock Chart CGC Stock Chart Receive ABOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ABOS) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.It could very well mark the beginning of a new multitrillion-dollar industrial revolution. Up until now, we...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump Nominates “Next Elon”Elon's Replacement? You've been told Elon Musk has been forced out of DC. But did you know his successor ha...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acumen Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acumen Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABOS Stock Free ABOS Stock Alerts